Eric Assénat
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research 37
- Colorectal Cancer Treatments and Studies 36
- Cancer Treatment and Pharmacology 13
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 60
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 26
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 15
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 17
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 27
- Co-authors
- Marc YchouRosine GuimbaudJean‐Luc RaoulFrançoise DesseigneChristelle de la FouchardièreJean‐Baptiste BachetOlivier BouchéMichel Ducreux
- Cited by
- OncologyHepatologyCancer Research
- Partner nations
- FranceItalyUnited States
In The Last Decade
Eric Assénat
168 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 7.2k
- Hepatology 1.6k
- Cancer Research 2.7k
- Pulmonary and Respiratory Medicine 2.5k
- Epidemiology 2.0k
Countries citing papers authored by Eric Assénat
This map shows the geographic impact of Eric Assénat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Assénat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Assénat more than expected).
Fields of papers citing papers by Eric Assénat
This network shows the impact of papers produced by Eric Assénat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Assénat. The network helps show where Eric Assénat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Assénat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 43 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 5 | |
| 13 | 2019 | 27 | |
| 14 | 2018 | 48 | |
| 15 | 2018 | 64 | |
| 16 | 2015 | 284 | |
| 17 | 2012 | 21 | |
| 18 | 2011 | 41 | |
| 19 | 転移性結腸直腸癌(MCRC)患者の第一線治療としてのFOLFIRINOXと併用したセツキシマブを評価する多施設第二相試験の最終結果 | 2009 | 2 |
| 20 | [Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment]. | 2007 | 1 |
About Eric Assénat
Eric Assénat is a scholar working on Hepatology, Oncology and Cancer Research, having authored 176 papers that have together received 10.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (60 papers), Pancreatic and Hepatic Oncology Research (37 papers), Colorectal Cancer Treatments and Studies (36 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers), Cancer Genomics and Diagnostics (26 papers), Liver Disease Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Treatment and Pharmacology (13 papers). The work is most often cited by research in Oncology (7.2k citations), Hepatology (1.6k citations) and Cancer Research (2.7k citations). Eric Assénat has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Marc Ychou, Rosine Guimbaud, Jean‐Luc Raoul, Françoise Desseigne, Christelle de la Fouchardière, Jean‐Baptiste Bachet, Olivier Bouché, Michel Ducreux, Y. Bécouarn and Antoine Adenis. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, Journal of Hepatology and Digestive and Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.